In its latest press release the FDA has stated that Med Prep Consulting Inc. of Tinton Falls, N.J., a specialty pharmacy licensed by the state of New Jersey is a specialty pharmacy is issuing a nationwide voluntary recall of all Sterile Drug Products. The recall was initiated by the company after some health care professionals at a hospital in Connecticut observed floating particles, later identified to be a fungus, in five bags of magnesium sulfate intravenous solution.

According to reports from the sources the contaminated products was distributed to some of the health care units and facilities in Pennsylvania, New Jersey, Connecticut, Delaware and Pennsylvania. In the released safety notification the federal agency has asked physicians and healthcare providers to stop the use of all products manufactured by the same facility.

While briefing about the negative consequences of using a contaminated injectable drug the director of the FDA’s Center for Drug Evaluation and Research, Janet Woodcock said “Giving a patient a contaminated injectable drug could result in a life-threatening infection,” “We do not have reports of patient infections. However, due to a lack of sterility assurance at the facility and out of an abundance of caution, this recall is necessary to protect patients.”

According to reports from sources, the FDA is working with the Centers for Disease Control and Prevention and other local agencies to get into the root of the contamination. FDA says it is important for all of us to determine the scope of the contamination so as to avoid repetition of the same. In the product recall issued by the FDA the recall is applicable to all of the products manufactured and distributed through March 15, 2013. The level of recall is to the user level, this includes regional hospital pharmacies and related departments, and physician’s office practices.

After this released notification, the firm has temporarily halted all production operations, including the processing and shipping of medications. To date, no reports of injury or illness associated with the recalled magnesium sulfate intravenous solution was reported however the recall was initiated as a precautionary measures. The FDA asks health care professionals and consumers to report any adverse reactions to the FDA’s MedWatch program:

About Med Prep Consulting:

Med Prep Consulting Inc. is one of the renowned names in the field of drug and pharmaceutical sector which prepares a number of sterile products for intravenous administration for a number of medical conditions. Some of the products that the company manufactures are general and local anesthetics, antibiotics, cardiac, labor and delivery and pain management medications.